Radiation Failure on Treating Prostate Cancer

Posted: Jan 25, 2011 |Comments: 0 |

HIFU (high-intensity focused ultrasound) uses high-energy sound waves to destroy prostate cancer cells without radiation. Intersecting, precision-focused ultrasound waves raise the temperature in the targeted cancerous tissue to more than 80–90 degrees Celsius in seconds, effectively destroying the tissue.

Unlike radiation therapies, ultrasound energy is non-ionizing "clean energy" that does not damage tissue surrounding the target zone. The target zone is approximately 1/8 inch in diameter, which allows greater precision than radiation therapies. Unlike radiation therapy, HIFU treatments may be repeated in the event that the disease recurs locally. HIFU may also be used as a salvage therapy following failed radiation therapy.

The HIFU procedure is performed on an outpatient basis, meaning that a hospital stay is usually not necessary. The procedure is performed under spinal or general anesthesia and typically takes approximately 2 hours. During the procedure, a small probe is inserted into the rectum which generates and emits the ultrasound energy that is precisely targeted to the prostate. Physician will monitor the prostate throughout the procedure using real-time ultrasound images to maximize prostate cancer destruction and minimize injury to other vital tissues.

HIFU treatment for prostate cancer has not yet been approved by the U.S. Food and Drug Administration. However, to date, over 6,000 men have undergone HIFU at over 100 International HIFU Centers throughout the globe. Every year, over 40,000 men with prostate cancer who are treated with radiation have their cancers return. The majority of these men will choose hormonal therapy in an attempt to control their cancer. Hormonal therapy prohibits the production of testosterone in order to slow down the cancer's growth. However, lowering of testosterone may cause side effects such as osteoporosis, increased risk of heart attack, stroke, loss of libido, depression, loss of mental acuity and impotence. HIFU is radiation free and destroys residual cancer in the prostate using clean ultrasound energy. In a small U.S. safety trial, 91% of the participants had a negative biopsy 6 months after the HIFU treatment.

The typical short-term side effects associated with radiation therapy include fatigue and urinary and rectal symptoms. Urinary symptoms may include frequency, urgency, urge incontinence, nocturia and diminished urinary stream. Rectal symptoms may include diarrhea, fecal incontinence, rectal bleeding and rectal urgency. In most cases, the urinary and rectal symptoms are transient. In addition, erectile dysfunction often develops months or years after radiation therapy. Long-term complications are rare and include rectal or urinary fistulas, urinary strictures, hemorrhagic cystitis and proctitis (chronic bleeding from the rectum and bladder) and dysfunctional bladder or rectum due to scarring. There is increasing evidence that men undergoing pelvic radiation are at significantly greater risk of developing bladder and colon cancer.

Salvage radical prostatectomy is also a very challenging technical procedure because of the prostate is embedded in a fibrous scar produced by radiation. Therefore, minimally invasive ablative therapies are gaining increasing acceptance for the treatment of recurrent prostate cancer after failed radiation therapy which is indeed HIFU. Many patients who have had radiation therapy, brachytherapy or external beam radiation experience a rise in PSA have discovered that the cancer is back. These patients may be candidates for HIFU as well, as long as the cancer has not spread to the bone or other organs. Additionally, patients who have a local recurrence after receiving a radical prostatectomy may also qualify for HIFU.

Questions and Answers

Ask
200 Characters left
Rate this Article
  • 1
  • 2
  • 3
  • 4
  • 5
  • 0 vote(s)
    Feedback
    Print
    Re-Publish
    Source:  http://www.articlesbase.com/cancer-articles/radiation-failure-on-treating-prostate-cancer-4104105.html

    Article Tags:

    hifu

    ,

    hifu treatment

    ,

    orlando urologist

    ,

    orlando urology

    ,

    urology services

    Richard R. Lotenfoe

    NanoKnife is a device which implements technology called irreversible electroporation to electrically target and kill specific tumor cells. The "NanoKnife" is actually an electric field – that can be precisely targeted to "poke" tiny holes in tumor cells, while not affecting adjacent organs. The ultra-precision of the NanoKnife allows physicians to treat tumors that in the past would have been difficult or impossible for surgeons to operate on because of their location.

    By: Richard R. Lotenfoel Health> Cancerl Jan 27, 2011 lViews: 134

    Cancer translational research brings together scientists' and clinicians' suggestions to develop solutions to biomedical complications. This kind of applied research strives to offer strategies to questions surrounding the etiology, pathology, diagnosis, prevention and treating cancer.

    By: Terry Dancerl Health> Cancerl May 30, 2012

    Orbs are actually a lumpectomy or quadrantectomy combined with rotating the breast tissue or mobilize the flap into the cavity of the surgery time fill is removed. It also includes the comparative change in shape and size is doing in relation to breast and moved if necessary, does not affect the conversion of the breast. The deferred plan the reconstruction is not part of endoplasmic techniques. Both procedures are performed by specific thoracic surgeons.

    By: Omer Faroohl Health> Cancerl May 28, 2012

    What every woman fears for is losing her self confidence , losing hope and losing her personality. The term "Breast Cancer" is a very negative word and that it creates negative vibrations in her heart. So, to make her comfortable with the basics of breast cancer and to make her means any woman understand that this type of cancer is the least dangerous than all cancers and that if it is detected early then you will fight with it successfully. Causes, Symptoms, treatment, discussed in detail.

    By: Medha Srikanthl Health> Cancerl May 27, 2012
    Myra Foreman

    Mesothelioma is a rare cancer that originates in the mesothelium. The mesothelium is the protective lining that covers the body's internal organs. Mesothelioma occurs when the mesothelium cells start to divide uncontrollably.

    By: Myra Foremanl Health> Cancerl May 27, 2012

    Chemotherapy is a treatment for killing cancerous cells which is given intravenous or extra-venous to the cancer patient. Even breast cancer patients have to go through the treatment. This treatment mainly focuses on the cancerous cells that are spread in the blood stream in the whole body . If any cancerous cells are there then they are killed by the chemotherapy medicine. The medicine is very costly and it has to be taken for one or two days continuously for every 21 days .

    By: Medha Srikanthl Health> Cancerl May 25, 2012
    Richard R. Lotenfoe

    Through the evolution of modern medicine, medical physicians have now come up with a new prostate cancer treatment known in many circles as HIFU, which stands for high intensity focused ultrasound. This new technology assists men suffering from prostate cancer by getting rid of all cancer infected tissue in the prostate region using an advanced acoustic ablation method that utilizes the powers of an ultrasound.

    By: Richard R. Lotenfoel Health> Cancerl Aug 17, 2011
    Richard R. Lotenfoe

    The Sonblate 500 is a minimal invasive treatment technique using a transrectal probe to ensure focus of ultrasound waves on the prostate, to a targeted and precise location. It raises the temperature, causes the tissue to break down, treating the entire prostate. HIFU using the Sonablate 500 takes at most four hours a

    By: Richard R. Lotenfoel Health> Cancerl Jun 06, 2011
    Richard R. Lotenfoe

    Male pattern baldness can be associated with prostate cancer. The prevalence of male pattern baldness is common among males in the United States. It is found that factors including heritability and androgens are associated to having a cause in both male pattern baldness and prostate cancer. Male pattern baldness is known to affect about 50 percent of the male population. The proven link between prostate cancer and male pattern baldness continues to be a subject of research up to now.

    By: Richard R. Lotenfoel Health> Cancerl May 18, 2011
    Richard R. Lotenfoe

    The prevailing study analyzed the lack of prognostic knowledge regarding the abandonment of Gleason score (GS) 2-4 by the International Society of Urological Pathology (ISUP-2005). Within a ten-year period ahead of the modification of GS, 856 patients (mean age 64.2 years) underwent radical prostatectomy (RP). The grade of agreement between GS in biopsy and definitive histology was calculated by Kappa statistics (k). Grades are in accordance with the level to which the epithelium assumes an or

    By: Richard R. Lotenfoel Health> Cancerl Apr 05, 2011
    Richard R. Lotenfoe

    Men who have tried External Beam Radiation Therapy (EBRT) or Interstitial Brachytherapy for clinically localized prostate cancer possess a 20-30% greater probability of having prostate-specific antigen (PSA) failure. Salvage therapy is indicated when men are treated with radiotherapy, brachytherapy, or a combination of these for presumed localized prostate cancer and have a recurrence.

    By: Richard R. Lotenfoel Health> Cancerl Mar 23, 2011

    Discuss this Article

    Author Box
    Articles Categories
    All Categories
    Quantcast